The company claims its semaglutide drops, which are applied under the tongue, contain the same active ingredient found in Ozempic and Wegovy and provide the powerful benefits of GLP-1 without injections. EllieMD further touts, under a benefits tab on the drops product page, that the drops offer prescription appetite suppression and are scientifically backed to help users lose weight, adding that the drops can help to lower blood sugar levels and potentially reduce the risk factors associated with conditions like type 2 diabetes, high blood pressure and cardiovascular disease, which are often linked to diabetes. Meanwhile, a recent EllieMD Instagram post boasts about the cardiovascular benefits of its GLP-1 medication, including decreased risk of cardiovascular disease, heart attack and stroke
Glutathione is outstanding at scavenging free radicals before they can cause cellular stress, thereby protecting the cells so they can function optimally
Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks
However, the FDA has stated that salt forms of semaglutide are not components of the approved drug and raise safety questions